Indegene Limited (NSE:INDGN) filed its 28th Annual General Meeting voting results with the exchanges on 17 August 2026, confirming that all resolutions placed before shareholders on 13 August 2026 were passed with the requisite majority through remote e-voting and e-voting conducted during the meeting.
Key Highlights
- The 28th AGM of Indegene Limited was held on Thursday, 13 August 2026, at 4:30 PM IST via Video Conferencing and Other Audio-Visual Means, in compliance with MCA circulars and the Companies Act, 2013.
- All resolutions as stated in the AGM Notice dated 17 July 2026 were passed with the requisite majority, combining remote e-voting held prior to the meeting and e-voting conducted during the AGM.
- The Scrutinizer's Report, dated 15 August 2026, was prepared under Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014.
- The combined voting results and Scrutinizer's Report were submitted to both BSE Limited and the National Stock Exchange of India Limited on 17 August 2026, as required under Regulation 44 of the SEBI Listing Regulations.
About the Company
Indegene Limited (NSE:INDGN) is a Bengaluru-headquartered, technology-led healthcare commercialisation company incorporated in 1998. It serves biopharmaceutical, medical device, and emerging biotech clients globally, providing services spanning medical affairs, regulatory submissions, clinical trial operations, and omnichannel commercial engagement. The company is listed on both the NSE and BSE under ticker INDGN and scrip code 544172 respectively, and operates within India's IT and healthcare services sector.
Announcement in Detail
Indegene Limited convened its 28th AGM on 13 August 2026 at 4:30 PM IST through Video Conferencing and Other Audio-Visual Means, in accordance with applicable MCA circulars and provisions of the Companies Act, 2013 read with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The AGM Notice was dated 17 July 2026, and the resolutions transacted were those stated therein.
The Company Secretary and Compliance Officer, Srishti Ramesh Kaushik, filed the combined remote e-voting and AGM e-voting results as Annexure A, along with the Scrutinizer's Report dated 15 August 2026 as Annexure B, with both exchanges on 17 August 2026. The filing confirms all resolutions were passed with the requisite majority, and the information has been made available on the company's official website as well.
Impact on Investors
Investors will note that all resolutions tabled at the 28th AGM have been formally adopted following the combined e-voting process, making them binding on the company. The filing shows the voting was conducted through National Securities Depository Limited's e-voting platform, and shareholders who did not cast their votes through remote e-voting were provided the facility to do so during the AGM itself. The disclosed terms indicate no resolutions were rejected or deferred.
Shareholders will observe that the submission complies with Regulation 44 of the SEBI Listing Regulations, which mandates disclosure of voting results within 48 hours of an AGM's conclusion. The filing does not disclose specific vote counts, percentages, or the precise subject matter of each resolution in the exchange announcement itself; investors are directed to review the full Annexures A and B submitted to the exchanges for those details.
Sector / Market Context
India's technology-enabled healthcare services sector has expanded steadily over recent years, with domestic IT and healthcare services firms increasingly serving global life sciences clients. SEBI's continued emphasis on electronic shareholder participation, including mandatory e-voting and disclosure of scrutinizer reports under Regulation 44 of the SEBI Listing Regulations, reflects the broader governance strengthening framework applied to all listed Indian companies. The Ministry of Corporate Affairs has progressively enabled virtual general meetings since 2020, a facility that listed entities such as Indegene continue to utilise in accordance with applicable circulars for conducting annual shareholder meetings.